2021 Q1 Form 10-K Financial Statement
#000156459021016653 Filed on March 30, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q4 | 2020 |
---|---|---|---|
Revenue | $1.658M | $1.476M | $7.128M |
YoY Change | -29.75% | -47.97% | -24.75% |
Cost Of Revenue | $615.0K | $643.0K | $2.781M |
YoY Change | -28.24% | -55.22% | -29.29% |
Gross Profit | $1.043M | $833.0K | $4.347M |
YoY Change | -30.61% | -40.54% | -21.52% |
Gross Profit Margin | 62.91% | 56.44% | 60.98% |
Selling, General & Admin | $1.395M | $1.336M | $6.177M |
YoY Change | -15.71% | -61.83% | -25.94% |
% of Gross Profit | 133.75% | 160.38% | 142.1% |
Research & Development | $215.0K | $988.0K | |
YoY Change | -29.04% | -28.72% | |
% of Gross Profit | 20.61% | 22.73% | |
Depreciation & Amortization | $66.00K | $61.00K | $253.0K |
YoY Change | 4.76% | -25.61% | -11.23% |
% of Gross Profit | 6.33% | 7.32% | 5.82% |
Operating Expenses | $1.395M | $1.566M | $7.165M |
YoY Change | 360.4% | -59.69% | -26.34% |
Operating Profit | -$567.0K | -$733.0K | -$2.818M |
YoY Change | 24.62% | -70.49% | -50.8% |
Interest Expense | $32.00K | $12.00K | $113.0K |
YoY Change | 14.29% | -105.24% | 46.75% |
% of Operating Profit | |||
Other Income/Expense, Net | -$32.00K | $94.00K | |
YoY Change | -139.02% | -93.57% | |
Pretax Income | -$599.0K | -$721.0K | -$2.724M |
YoY Change | 60.59% | -73.42% | -36.13% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$599.0K | -$721.0K | -$2.724M |
YoY Change | 60.59% | -73.42% | -36.13% |
Net Earnings / Revenue | -36.13% | -48.85% | -38.22% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$79.45K | -$95.64K | -$361.3K |
COMMON SHARES | |||
Basic Shares Outstanding | 7.539M | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q1 | 2020 Q4 | 2020 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.117M | $689.0K | $689.0K |
YoY Change | 57.77% | 42.36% | 42.36% |
Cash & Equivalents | $1.117M | $689.0K | |
Short-Term Investments | |||
Other Short-Term Assets | $437.0K | $174.0K | $174.0K |
YoY Change | 0.69% | -15.94% | -15.94% |
Inventory | $1.055M | $917.0K | $917.0K |
Prepaid Expenses | |||
Receivables | $437.0K | $403.0K | $403.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $3.046M | $2.183M | $2.183M |
YoY Change | -9.88% | -36.76% | -36.76% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.297M | $534.0K | $1.408M |
YoY Change | 105.87% | -20.06% | 1.66% |
Goodwill | |||
YoY Change | |||
Intangibles | $1.262M | ||
YoY Change | -5.47% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $434.0K | $434.0K | $434.0K |
YoY Change | -3.13% | -3.13% | -3.13% |
Total Long-Term Assets | $2.973M | $3.104M | $3.104M |
YoY Change | -14.96% | -2.02% | -2.02% |
TOTAL ASSETS | |||
Total Short-Term Assets | $3.046M | $2.183M | $2.183M |
Total Long-Term Assets | $2.973M | $3.104M | $3.104M |
Total Assets | $6.019M | $5.287M | $5.287M |
YoY Change | -12.46% | -20.14% | -20.14% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $512.0K | $360.0K | $360.0K |
YoY Change | -4.12% | -44.95% | -44.95% |
Accrued Expenses | $888.0K | $386.0K | $732.0K |
YoY Change | 23.68% | -39.88% | -27.45% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $2.852M | $0.00 | $0.00 |
YoY Change | 19.08% | ||
Long-Term Debt Due | $219.0K | $141.0K | $141.0K |
YoY Change | |||
Total Short-Term Liabilities | $4.721M | $1.483M | $1.483M |
YoY Change | 12.27% | -22.48% | -22.48% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $915.0K | $2.992M | $2.992M |
YoY Change | 26.24% | 26.24% | |
Other Long-Term Liabilities | $781.0K | $845.0K | $845.0K |
YoY Change | -35.67% | -8.65% | -8.65% |
Total Long-Term Liabilities | $1.696M | $3.837M | $3.837M |
YoY Change | 39.7% | 16.45% | 16.45% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.721M | $1.483M | $1.483M |
Total Long-Term Liabilities | $1.696M | $3.837M | $3.837M |
Total Liabilities | $6.417M | $5.320M | $5.320M |
YoY Change | 18.42% | 2.15% | 2.15% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$109.1M | ||
YoY Change | 2.56% | ||
Common Stock | $8.000K | ||
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$4.698M | -$4.333M | -$33.00K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $6.019M | $5.287M | $5.287M |
YoY Change | -12.46% | -20.14% | -20.14% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q4 | 2020 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$599.0K | -$721.0K | -$2.724M |
YoY Change | 60.59% | -73.42% | -36.13% |
Depreciation, Depletion And Amortization | $66.00K | $61.00K | $253.0K |
YoY Change | 4.76% | -25.61% | -11.23% |
Cash From Operating Activities | -$394.0K | -$311.0K | -$341.0K |
YoY Change | -248.68% | -18.37% | -75.59% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.000K | -$26.00K | $28.00K |
YoY Change | -166.67% | -73.47% | -82.93% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$2.000K | -$26.00K | -$108.0K |
YoY Change | -95.12% | -73.47% | -78.14% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 824.0K | 0.000 | 654.0K |
YoY Change | -100.0% | -49.69% | |
NET CHANGE | |||
Cash From Operating Activities | -394.0K | -311.0K | -341.0K |
Cash From Investing Activities | -2.000K | -26.00K | -108.0K |
Cash From Financing Activities | 824.0K | 0.000 | 654.0K |
Net Change In Cash | 428.0K | -337.0K | 205.0K |
YoY Change | 91.07% | -1704.76% | -134.69% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$394.0K | -$311.0K | -$341.0K |
Capital Expenditures | -$2.000K | -$26.00K | $28.00K |
Free Cash Flow | -$392.0K | -$285.0K | -$369.0K |
YoY Change | -249.62% | 0.71% | -76.36% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q2 | isco |
Paycheck Protection Program Loan Maturity Period
PaycheckProtectionProgramLoanMaturityPeriod
|
P2Y | |
CY2020Q2 | isco |
Paycheck Protection Program Loan Forgiveness Period
PaycheckProtectionProgramLoanForgivenessPeriod
|
P168D | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2537000 | |
CY2020 | dei |
Entity Registrant Name
EntityRegistrantName
|
International Stem Cell CORP | |
CY2020 | dei |
Entity File Number
EntityFileNumber
|
0-51891 | |
CY2020 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4494098 | |
CY2020 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2020 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2020 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001355790 | |
CY2020 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2020 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2020 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2020 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5950 Priestly Drive | |
CY2020 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Carlsbad | |
CY2020 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2020 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92008 | |
CY2020 | dei |
City Area Code
CityAreaCode
|
760 | |
CY2020 | dei |
Local Phone Number
LocalPhoneNumber
|
940-6383 | |
CY2020Q2 | dei |
Entity Public Float
EntityPublicFloat
|
2853000 | |
CY2021Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7539089 | |
CY2020 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2020 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2020 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2020 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2020Q4 | us-gaap |
Cash
Cash
|
689000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
403000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
917000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
174000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2183000 | |
CY2020Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
371000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
534000 | |
CY2020Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1262000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1483000 | |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1913000 | |
CY2020Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2475000 | |
CY2019Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2370000 | |
CY2020 | dei |
Security12g Title
Security12gTitle
|
Common Stock, $0.001 par value per share | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-109115000 | |
CY2020 | dei |
Security Exchange Name
SecurityExchangeName
|
NONE | |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-106391000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4333000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2888000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5287000 | |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6620000 | |
CY2020 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2019Q4 | us-gaap |
Cash
Cash
|
484000 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1515000 | |
CY2019Q4 | us-gaap |
Inventory Net
InventoryNet
|
1246000 | |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
207000 | |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3452000 | |
CY2019Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
358000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
668000 | |
CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1335000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
874000 | |
CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
717000 | |
CY2020Q4 | isco |
Deposits And Other Assets
DepositsAndOtherAssets
|
63000 | |
CY2019Q4 | isco |
Deposits And Other Assets
DepositsAndOtherAssets
|
90000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
5287000 | |
CY2019Q4 | us-gaap |
Assets
Assets
|
6620000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
360000 | |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
654000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
386000 | |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
642000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
346000 | |
CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
367000 | |
CY2020Q4 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
CY2019Q4 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
CY2020Q4 | isco |
Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
|
141000 | |
CY2020Q4 | isco |
Paycheck Protection Program Loan Noncurrent
PaycheckProtectionProgramLoanNoncurrent
|
517000 | |
CY2019Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
207000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
845000 | |
CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
718000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
5320000 | |
CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
5208000 | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
104769000 | |
CY2019Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
103490000 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
CY2019 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2087000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-2724000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1279000 | |
CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
253000 | |
CY2019 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
285000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7539089 | |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7539089 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7539089 | |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7539089 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7128000 | |
CY2019 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
9472000 | |
CY2020 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ProductMember | |
CY2019 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ProductMember | |
CY2019 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3933000 | |
CY2020 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
9946000 | |
CY2019 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
15200000 | |
CY2019 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5728000 | |
CY2020 | us-gaap |
Interest Expense
InterestExpense
|
113000 | |
CY2019 | us-gaap |
Interest Expense
InterestExpense
|
77000 | |
CY2019 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
2000 | |
CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
94000 | |
CY2019 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1463000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2724000 | |
CY2019 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4265000 | |
CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.36 | |
CY2019 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.57 | |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7539000 | |
CY2019 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7513000 | |
CY2019 | isco |
Adjustments Related To Error Correction In Equity
AdjustmentsRelatedToErrorCorrectionInEquity
|
-4300000 | |
CY2019 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1049000 | |
CY2019 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4000 | |
CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
-4265000 | |
CY2020 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
265000 | |
CY2019 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
289000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1279000 | |
CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2087000 | |
CY2019 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
4000 | |
CY2019 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
73000 | |
CY2020 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
65000 | |
CY2019 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
1540000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1112000 | |
CY2019 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
864000 | |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-316000 | |
CY2019 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-702000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-33000 | |
CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-336000 | |
CY2020 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-27000 | |
CY2019 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
12000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-294000 | |
CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
196000 | |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-256000 | |
CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
74000 | |
CY2020 | isco |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-315000 | |
CY2019 | isco |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-304000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-341000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1397000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
28000 | |
CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
164000 | |
CY2020 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
80000 | |
CY2019 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
330000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-108000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-494000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
654000 | |
CY2019 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1300000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
654000 | |
CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1300000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
205000 | |
CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-591000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
484000 | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1075000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
689000 | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
5000 | |
CY2019 | us-gaap |
Interest Paid Net
InterestPaidNet
|
5000 | |
CY2020 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
421000 | |
CY2020 | isco |
Patent License Costs Included In Accrued Liabilities
PatentLicenseCostsIncludedInAccruedLiabilities
|
3000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1187000 | |
CY2020 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2019, the Company reclassified certain prior period amounts to conform to the current period presentation, as follows:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying value and shares of the Company’s Series B, Series G, Series I-1 and Series I-2 non-redeemable convertible preferred stock were aggregated on the accompanying consolidated balance sheets and consolidated statements of changes in redeemable convertible preferred stock and stockholders’ deficit. Refer to Note 6 – Convertible Preferred Stock, for further discussion;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash operating lease expense was reclassified from changes in operating assets and liabilities to adjustments to reconcile net loss to net cash used in operating activities on the accompanying consolidated statements of cash flows; and</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for inventory obsolescence was reclassified from adjustments to reconcile net loss to net cash used in operating expenses to inventory, net, in the changes in operating assets and liabilities on the accompanying consolidated statements of cash flows.</p></td></tr></table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These reclassifications had no effect on previously reported net loss, stockholders’ deficit, or cash flows for the prior period.</p> | |
CY2020Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | |
CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values, allowance for excess and obsolete inventories, allowance for sales returns and doubtful accounts, and transactions using the Black-Scholes option valuation model, for example, common stock options and warrants, as well as the Monte-Carlo simulation method for certain common stock warrants. Actual results could differ from those estimates.</p> | |
CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Customer Concentrations</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2020, one major customer accounted for approximately 41% of product sales. For the year ended December 31, 2019, two major customers accounted for 37% and 15% of product sales, respectively. No other single customer accounted for more than 10% of product sales for the year ended.</p> | |
CY2020 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1099000 | |
CY2020Q4 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1262000 | |
CY2020 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
65000 | |
CY2020Q2 | isco |
Cares Act Of2020 Aid Amount
CARESActOf2020AidAmount
|
654000 | |
CY2020Q2 | isco |
Paycheck Protection Program Loan Interest Rate
PaycheckProtectionProgramLoanInterestRate
|
0.01 | |
CY2020Q2 | isco |
Paycheck Protection Program Loan Deferred Payment Period
PaycheckProtectionProgramLoanDeferredPaymentPeriod
|
P10M | |
CY2020 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | |
CY2020 | isco |
Number Of Business Units
NumberOfBusinessUnits
|
2 | |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
CY2008Q2 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
CY2008Q2 | isco |
Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
|
250000 | |
CY2020 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P15Y | |
CY2019 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
156000 | |
CY2020Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2286000 | |
CY2019Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2268000 | |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1008000 | |
CY2020 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | |
CY2020Q4 | isco |
Number Of Products Categories
NumberOfProductsCategories
|
2 | |
CY2020 | isco |
Number Of Sales Channels
NumberOfSalesChannels
|
2 | |
CY2020 | us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
The Company's revenue consists primarily of sales of products from its two revenue-generating operating segments, the biomedical products market and anti-aging products market. The biomedical market segment markets and sells primary human cell research products with two product categories, cells and media, which are sold both domestically within the United States and internationally. The anti-aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers | |
CY2020 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | |
CY2019 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | |
CY2020 | isco |
Product Return Guarantee Period
ProductReturnGuaranteePeriod
|
P30D | |
CY2020 | isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | |
CY2019 | isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | |
CY2020Q4 | isco |
Financial Assets Fair Value Disclosure
FinancialAssetsFairValueDisclosure
|
0 | |
CY2020Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
0 | |
CY2020Q4 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
CY2020Q4 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
CY2020Q4 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2020Q4 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
1745000 | |
CY2019Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
207000 | |
CY2020Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
0 | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14734547 | |
CY2019 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15020003 | |
CY2020Q4 | us-gaap |
Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
|
true | |
CY2020Q4 | us-gaap |
Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
|
2020-01-01 | |
CY2020Q4 | us-gaap |
Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
|
true | |
CY2020 | us-gaap |
Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
|
us-gaap:AccountingStandardsUpdate201813Member | |
CY2020Q4 | isco |
Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
|
1288000 | |
CY2020 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
131000 | |
CY2019 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3438000 | |
CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3410000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2904000 | |
CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2742000 | |
CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
162000 | |
CY2019 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
1.5 | |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1260000 | |
CY2019Q4 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1335000 | |
CY2020Q4 | isco |
Finite Lived Pending Patents
FiniteLivedPendingPatents
|
139000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
93000 | |
CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | |
CY2020 | us-gaap |
Preferred Stock Voting Rights
PreferredStockVotingRights
|
The holders of Series B, Series D, and Series G are entitled to one vote for each share of common stock into which it would convert. The holders of Series I-1 and Series I-2 have no voting rights | |
CY2019Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1000000 | |
CY2019Q1 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
49000 | |
CY2020 | isco |
Convertible Common Stock Conversion Price
ConvertibleCommonStockConversionPrice
|
1.75 | |
CY2014Q4 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
62047 | |
CY2016Q1 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
11159995 | |
CY2014Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
CY2016Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
CY2020Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
19617322 | |
CY2020Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
604000 | |
CY2019 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y6M3D | |
CY2019Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
800000 | |
CY2019Q4 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
500000 | |
CY2019Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
500000 | |
CY2020 | isco |
Operating Loss Carryforwards Latest Expiration Year
OperatingLossCarryforwardsLatestExpirationYear
|
2037 | |
CY2020 | isco |
Operating Loss Carryforwards Expiration Date Description
OperatingLossCarryforwardsExpirationDateDescription
|
various years through 2037 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2020 | isco |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
-0.028 | |
CY2019 | isco |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
0.030 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.001 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.004 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.003 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.050 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.191 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.131 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Leases
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLeases
|
-0.001 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Leases
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLeases
|
0.018 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.054 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.183 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.068 | |
CY2019 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.010 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2020 | isco |
Loss Carryback Period
LossCarrybackPeriod
|
P5Y | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
18452000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1980000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2871000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
547000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
24384000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
23850000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
24384000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
23850000 | |
CY2019Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | |
CY2020 | isco |
Number Of Operating Leases
NumberOfOperatingLeases
|
3 | |
CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1191000 | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
464000 | |
CY2019 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
490000 | |
CY2020 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
7000 | |
CY2019 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
11000 | |
CY2020 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
211000 | |
CY2019 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
228000 | |
CY2020 | us-gaap |
Lease Cost
LeaseCost
|
682000 | |
CY2019 | us-gaap |
Lease Cost
LeaseCost
|
729000 | |
CY2020 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
509000 | |
CY2019 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
486000 | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y10M24D | |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y7D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1705 | |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1765 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
517000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
394000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
255000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
233000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
240000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1639000 | |
CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
448000 |